The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 20, 2019

Filed:

Aug. 25, 2016
Applicants:

Immunolight, Llc., Detroit, MI (US);

Duke University, Durham, NC (US);

Inventors:

Tuan Vo-Dinh, Chapel Hill, NC (US);

Jonathan P. Scaffidi, Durham, NC (US);

Venkata Gopal Reddy Chada, Durham, NC (US);

Benoit Lauly, Durham, NC (US);

Yan Zhang, Durham, NC (US);

Molly K. Gregas, Durham, NC (US);

Ian Nicholas Stanton, Durham, NC (US);

Joshua T. Stecher, Durham, NC (US);

Michael J. Therien, Durham, NC (US);

Frederic A. Bourke, Jr., Aspen, CO (US);

Harold Walder, Belville, NC (US);

Zak Fathi, Raleigh, NC (US);

Jennifer A. Ayres, Raleigh, NC (US);

Zhenyuan Zhang, Durham, NC (US);

Joseph H. Simmons, Tucson, AZ (US);

Stephen John Norton, Cary, NC (US);

Assignees:

IMMUNOLIGHT, LLC., Detroit, MI (US);

DUKE UNIVERSITY, Durham, NC (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61N 5/06 (2006.01); A61K 49/00 (2006.01); A61N 1/40 (2006.01); A61N 5/02 (2006.01); A61B 5/00 (2006.01); A61B 5/055 (2006.01); A61B 6/00 (2006.01); A61K 41/00 (2006.01); A61M 5/00 (2006.01); A61N 5/10 (2006.01); A61L 2/00 (2006.01); A61L 2/08 (2006.01); A61N 5/067 (2006.01);
U.S. Cl.
CPC ...
A61N 5/062 (2013.01); A61B 5/0059 (2013.01); A61B 5/0071 (2013.01); A61B 5/055 (2013.01); A61B 5/4848 (2013.01); A61B 6/481 (2013.01); A61K 41/0042 (2013.01); A61K 41/0052 (2013.01); A61K 41/0061 (2013.01); A61K 49/0039 (2013.01); A61L 2/0047 (2013.01); A61M 5/007 (2013.01); A61N 1/406 (2013.01); A61N 5/02 (2013.01); A61N 5/0601 (2013.01); A61N 5/0618 (2013.01); A61N 5/0622 (2013.01); A61N 5/0624 (2013.01); A61N 5/10 (2013.01); A61L 2/08 (2013.01); A61L 2202/21 (2013.01); A61L 2202/22 (2013.01); A61N 2005/063 (2013.01); A61N 2005/067 (2013.01); A61N 2005/0656 (2013.01); A61N 2005/0659 (2013.01); A61N 2005/0662 (2013.01); A61N 2005/1098 (2013.01);
Abstract

System for modifying a target structure which mediates or is associated with a biological activity, including treatment of conditions, disorders, or diseases mediated by or associated with a target structure, such as a virus, cell, subcellular structure or extracellular structure. The system can be used in methods which can be performed by application of an initiation energy to a subject in situ to activate a pharmaceutical agent directly or via an energy modulation agent, optionally in the presence of one or more plasmonics active agents, thus producing an effect on or change to the target structure.


Find Patent Forward Citations

Loading…